Biotech advances, new investments and merger activity have helped lift drugmakers like Alexion Pharmaceuticals (ALXN), Celgene (CELG) and Biogen Idec (BIIB) past the rest of the market, which has seen some ups and downs recently. Those companies as well as Perrigo (PRGO) and Actavis (ACT) are all on IBD’s Big Cap Screen of the Day, which features large stocks with strong earnings and price performance. Several also appear in IBD’s Leaderboard, a
The “Santa Claus rally” has sent stocks to new heights, but Zeltiq Aesthetics (ZLTQ), Ambarella (AMBA), WuXi Pharmatech (WX) and Jazz Pharmaceuticals (JAZZ) are outperforming the record-setting market. IBD’s Bolting Relative Strength Lines Screen of the Day ranks stocks based on their RS line, which measures a stock’s performance vs. the benchmark S&P 500. When the RS line hits a new high ahead of the stock, that suggests technical strength.
Internet stocks are often associated with cutting-edge technology trends and well-publicized buzz. They don’t always have a proven track record of superior fundamentals. But YY Inc. (YY), Qihoo 360 Technology (QIHU), LinkedIn (LNKD), HomeAway (AWAY) and Autohome (ATHM) are all part of IBD’s Top Fundamentals Screen of the Day. The stock screen sorts by the three-year earnings per share growth rate and latest quarterly earnings growth. YY, Qihoo 360